Gilead and Kite Oncology  

  • Booth: 15028

Gilead and Kite Oncology are creating the future of oncology to help bring more life to people with cancer. At Gilead, we are focused on delivering transformational science, maximizing speed to the patient and being a partner of choice. As the cell therapy leader, Kite’s singular focus is to treat and potentially cure cancer by harnessing the power of a patient’s own immune system. We are focused on delivering therapies for some of the most difficult-to-treat cancers. Together, Gilead and Kite Oncology provide hope for many types of tumors where there remains high unmet need.


 Products

  • TRODELVY® (sacituzumab govitecan-hziy)
    See TRODELVY full Prescribing Information (https://www.gilead.com/-/media/files/pdfs/medicines/oncology/trodelvy/trodelvy_pi.pdf), including BOXED WARNING for neutropenia and diarrhea....

  • See TRODELVY full Prescribing Information, including BOXED WARNING for neutropenia and diarrhea.

  • YESCARTA® (axicabtagene ciloleucel)
    See YESCARTA full Prescribing Information (https://www.gilead.com/-/media/files/pdfs/medicines/oncology/yescarta/yescarta-pi.pdf), including BOXED WARNING for cytokine release syndrome and neurological toxicities....

  • See YESCARTA full Prescribing Information, including BOXED WARNING for cytokine release syndrome and neurological toxicities.


 Additional Info

Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
Yes